Publication:
Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Simple item page
dc.contributor.authorsYalcin, Suayib; Dane, Faysal; Oksuzoglu, Berna; Yildirim, Nuriye; Isikdogan, Abdurrahman; Ozkan, Metin; Demirag, Guzin; Coskun, Hasan Senol; Karabulut, Bulent; Evrensel, Turkkan; Ustaoglu, Mehmet Ali; Ozdemir, Feyyaz; Turna, Hande; Yavuzsen, Tugba; Aykan, Faruk; Sevinc, Alper; Akbulut, Hakan; Yuce, Deniz; Hayran, Mutlu; Kilickap, Saadettin
dc.date.accessioned2022-03-12T16:24:02Z
dc.date.accessioned2026-01-11T11:41:35Z
dc.date.available2022-03-12T16:24:02Z
dc.date.issued2018
dc.identifier.doi10.1200/JCO.2018.36.4_suppl.346
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/226180
dc.identifier.wosWOS:000436174100331
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleQuality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.issue4
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume36

Files

Collections

Araştırma Çıktıları